Profile
Owen B. Wallace is a former Senior Director at Eli Lilly & Co. from 2010 to 2013.
He also worked as a Senior Director of Discovery Chemistry Research at Lilly Research Centre Ltd. He then served as the Head of Global Discovery Chemistry at Novartis Institutes for Biomedical Research, Inc. from 2013 to 2017.
After that, he held the position of Chief Scientific Officer at Fulcrum Therapeutics, Inc. from 2017 to 2021.
Currently, he is the Chief Scientific Officer at Monte Rosa Therapeutics, Inc. Dr. Wallace obtained his graduate and doctorate degrees from Yale University and completed his undergraduate studies at University College Cork.
Former positions of Owen Wallace
| Companies | Position | End |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/05/2024 |
| FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/02/2021 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/04/2017 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2013 |
Lilly Research Centre Ltd. | Corporate Officer/Principal | - |
Training of Owen Wallace
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Cork
University College Cork Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Lilly Research Centre Ltd. | |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Owen Wallace
















